The possibilities of combination immunotherapy with radiation therapy for the treatment of patients with inoperable locally advanced non-small cell lung cancer

Currently, lung cancer is a global problem and public health issue in the world. Chemoradiotherapy remains the optimal method in the treatment of patients with unresectable non-small cell lung cancer (NSCLC). Nowadays, immune response checkpoint inhibitors (monoclonal antibodies) are actively introd...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: E. I. Smolenov, G. V. Afonin, V. S. Usachev, D. D. Kudryavtsev, I. V. Kolobaev, S. A. Ivanov
Format: Artigo
Idioma:Russo
Publicat: QUASAR, LLC 2021-06-01
Col·lecció:Issledovaniâ i Praktika v Medicine
Matèries:
non-small cell lung cancer
nsclc
radiotherapy
chemotherapy
immunotherapy
monoclonal antibody
pd inhibitor
chemoradiotherapy
Accés en línia:https://www.rpmj.ru/rpmj/article/view/727
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars